PHOTO
Aspetar Sports Medicine and Orthopaedic Hospital has launched a free coronavirus vaccination campaign targeting athletes based in Qatar. The first 50 injections were given on 22nd February. The programme was approved through Aspetar Executives who worked with the Healthcare Authority to be make Aspetar a designated Vaccination Centre. Dr Abdulaziz Al Kuwari, Aspetar CEO, said:
“We are committed to meet the vaccination needs of registered athletes and our staff as soon as possible. Thanks to our dedicated team, as this campaign would not be possible without the support of their tireless work across Aspetar, and that includes the many clinical providers and operations support who planned and executed the campaign.”
Dr Yorck Olaf Schumacher, Head of Infection Prevention and Control Committee at Aspetar, said: “The vaccination will not only prevent the COVID19 disease in the vaccinated person but will also prevent its spread, i.e. a vaccinated person is highly unlikely to infect others. Thus, vaccinations are not only protecting the vaccinated persons but also the unvaccinated persons around them by reducing the circulation of the virus.”
Aspetar aims to vaccinate all Aspire Zone staff and all registered athletes and are currently focusing on the first and second division QSL/QFA clubs. The current vaccination plan already includes more than 2000 people, Dr Schumacher added:
“We will hopefully have completed the course of two doses for all Aspire Zone staff and the Qatar stars league and QFA by the end of March. As of March 4th we have already vaccinated most of Aspetar AZF staff and about 650 athletes,We currently have a capacity of around 120 vaccinations a day, which we are aiming to increase to more than 150 in the coming days.”
The Aspetar COVID19 response team, which already successfully planned and implemented the COVID-19 testing programme for QSL is in charge again, and athletes will be contacted and scheduled by the medical staff of their club.
The Aspetar vaccination programme team is composed of representatives of different departments at Aspetar: Dr Khalid Hassoun is in charge of the club and QSL liaison; Mr Ibrahim Al Hussein manages operations along with the Infection Prevention and Control team; Mr Chris Mengelt communicates with Aspire Zone, MOPH, and other external stakeholders; and Dr Yorck Olaf Schumacher is the medical lead and overall supervision for the programme.
-Ends-
About Aspetar:
Aspetar is a world leading specialised orthopaedic and sports medicine hospital, and the first of its kind in the Middle East. Since 2007, with a world expert team, the hospital has provided top-level comprehensive medical treatment to all athletes in a state-of-the-art facility that sets new standards internationally.
In 2009, Aspetar was accredited as a “FIFA Medical Centre of Excellence” by F-MARC. In 2013, Aspetar was adopted as a reference collaborator centre by the Gulf Countries Council (GCC) Health Ministers Council and “IOC Research Centre for Prevention of Injury and Protection of Athlete Health” in 2014.
In 2015, Aspetar has been recognised as the “IHF Reference Centre for Athlete and Referee Health”. In the same year, the hospital also achieved the obtained on December 15 the Accreditation Canada International (ACI) “Platinum Level”.
Aspetar is a member–organisation of Aspire Zone Foundation, Qatar’s innovative sports and healthy lifestyle destination.
For more information: please contact
Lyes Fodil
PR and Media Relations Section
Office: +974 444132112
Lyes.fodil@aspetar.com
www.aspetar.com
Twitter: @Aspetar
Facebook.com/Aspetar
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
